Conversion from cyclosporine Sandimmune to cyclosporine Neoral in the stable renal transplant population.
Griffin
P J
PJ
Transplant Unit, Cardiff Royal Infirmary, United Kingdom.
Moore
R H
RH
Jurewicz
W A
WA
Lord
R H
RH
Webley
Y
Y
Jenkins
J
J
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004304:Dosage Forms; D016903:Drug Monitoring; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged
D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine